speb/financial-data huggingface dataset:
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 54767000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Normalized Income: 22501000.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 114622000.00
REGENCERAM.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: -134599000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Operating Income: -171696000.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Operating Income: -70512000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Operating Revenue: 131470000.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 70199000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 26441586.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 26441586.00
REGENCERAM.NS cash_flow (annual, 2025-03-31) — Other Cash Adjustment Outside Changein Cash: -1000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 252368000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 252368000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 185469000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 185469000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: -1000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: -1000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 8084000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 8084000.00
REGENCERAM.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: -114966000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: -4000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: -4000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 126210000.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 115475000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 135913000.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 65073000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Other Payable: 43024000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 43024000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 64326000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 64326000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 65822000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 65822000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Other Special Charges: -3039000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Payables: 474584000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Payables: 474584000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 97055000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 97055000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 199102000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 199102000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Pretax Income: -48781000.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 43340000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 81911000.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 49615000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 40534000.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 9804000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 26688000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 26688000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: -1052439000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -1052439000.00
REGENCERAM.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 13471000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 3661000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 22263000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Share Issued: 26441586.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 26441586.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Special Income Charges: 0.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: -600942000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: -600942000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: -609026000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -609026000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Tax Provision: -71282000.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Tax Provision: -71282000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.30
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.30
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 59333000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 59333000.00
REGENCERAM.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: 69812000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Total Assets: 985730000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 985730000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 104315000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 104315000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Total Debt: 773184000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 773184000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: -600942000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: -600942000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Total Expenses: 303166000.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 140711000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 1586672000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1586672000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 288048000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 288048000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 719787000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 719787000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 11000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 0.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Working Capital: -169203000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: -169203000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Write Off: 0.00
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 69925000.00
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 67204000.00
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 26487838.00
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — Basic EPS: -0.74
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 48490000.00
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 9691000.00
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 9691000.00
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 26487838.00
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.74
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -19601000.00
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — EBIT: -32898000.00
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — EBITDA: -23207000.00
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 18714000.00
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 1563000.00
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 1563000.00
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — Net Income: -19601000.00
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -19601000.00
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -19602000.00
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -19601000.00
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -19601000.00
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -19602000.00
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -1563000.00
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -1563000.00
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -23207000.00
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — Normalized Income: -19601000.00
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — Operating Income: -51211000.00
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 67204000.00
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 18314000.00
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 50661000.00
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — Pretax Income: -34461000.00
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 48490000.00
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 9691000.00
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — Tax Provision: -14859000.00
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.30
REGENCERAM.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 118415000.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 67764000.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 87607000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 473469000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 160009000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 74420000.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 26425625.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Basic EPS: -1.60
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 264416000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 2648000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 68566000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 264416000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -662823000.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 62013000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 826854000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 68330000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 68330000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 912857000.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 9755000.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 9755000.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 26425625.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: -1.60
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -42281000.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — EBIT: -40754000.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — EBITDA: -30999000.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 25594000.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 1527000.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 1527000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 322755000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 241364000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 74420000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 835857000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 835857000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 14530000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 901539000.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Net Income: -42281000.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -42281000.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -42281000.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -42281000.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -42281000.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -42281000.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -1527000.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -1527000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 181130000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -662823000.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -30999000.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Normalized Income: -42281000.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Operating Income: -42170000.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 87607000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 26441586.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 270679000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 224024000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: -927239000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 18017000.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 1416000.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 48904000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 65918000.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Payables: 473469000.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Pretax Income: -42281000.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 62013000.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 9755000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 26441586.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -662823000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -662823000.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 0.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 4845000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 1100421000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 173034000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 904187000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -662823000.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 129777000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1763244000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 273567000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 850387000.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
REGENCERAM.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
REGENCERAM.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: -86003000.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 107783000.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 115223000.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 26474872.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Basic EPS: -1.95
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 59513000.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 9778000.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 9778000.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 26474872.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: -1.95
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -51626000.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — EBIT: -50075000.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — EBITDA: -40297000.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 55710000.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 1551000.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 1551000.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Net Income: -51626000.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -51626000.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -51626000.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -51626000.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -51626000.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -51626000.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -1551000.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -1551000.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -40297000.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Normalized Income: -51626000.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Operating Income: -52073000.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 115223000.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 1998000.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 88110000.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Pretax Income: -51626000.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 59513000.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 9778000.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 0.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 167296000.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
REGENCERAM.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — +Operating Expense: 333188000.00
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 87716000.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — +Total Revenue: 382678000.00
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 112644000.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 482736000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 482736000.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 192050000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 192050000.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 74760000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 74760000.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 26435477.00
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 26414376.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — Basic EPS: -9.02
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — Basic EPS: -4.73
REGENCERAM.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 6912000.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 264416000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 264416000.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 12317000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 12317000.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 78310000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 78310000.00
REGENCERAM.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 73155000.00
REGENCERAM.NS cash_flow (annual, 2026-03-31) — Change In Payable: 51177000.00
REGENCERAM.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -245667000.00
REGENCERAM.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -121335000.00
REGENCERAM.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 5405000.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Common Stock: 264416000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 264416000.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: -839388000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: -839388000.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 322608000.00
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 152592000.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Current Assets: 945192000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 945192000.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Current Debt: 52416000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 52416000.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 52416000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 52416000.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 991216000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 991216000.00
REGENCERAM.NS cash_flow (annual, 2026-03-31) — Depreciation: 39245000.00
REGENCERAM.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 39245000.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 39245000.00
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 10021000.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 39245000.00
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 10021000.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 26435477.00
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 26414376.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — Diluted EPS: -9.02
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: -4.73
REGENCERAM.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: -238448000.00
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -124940000.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — EBIT: -247188000.00
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — EBIT: -123462000.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — EBITDA: -207943000.00
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — EBITDA: -113441000.00
REGENCERAM.NS cash_flow (annual, 2026-03-31) — End Cash Position: 12317000.00
REGENCERAM.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 334083000.00
REGENCERAM.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -342943000.00
REGENCERAM.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -120000.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — Gross Profit: 60070000.00
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — Gross Profit: -39948000.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — Interest Expense: 6119000.00
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 1478000.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 6119000.00
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 1478000.00
REGENCERAM.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 22285000.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Inventory: 279463000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 279463000.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 252368000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 252368000.00
REGENCERAM.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: 14265000.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 74760000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 74760000.00
REGENCERAM.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 334083000.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 1039340000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 1039340000.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1039340000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1039340000.00
REGENCERAM.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 334083000.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 14530000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 14530000.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Net Debt: 1079439000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 1079439000.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — Net Income: -238448000.00
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — Net Income: -124940000.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: -238448000.00
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -124940000.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: -238448000.00
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -124940000.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -238448000.00
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -124940000.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -238448000.00
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -124940000.00
REGENCERAM.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: -253307000.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: -238448000.00
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -124940000.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — Net Interest Income: -6119000.00
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -1478000.00
REGENCERAM.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -36000.00
REGENCERAM.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 334083000.00
REGENCERAM.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 334083000.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -6119000.00
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -1478000.00
REGENCERAM.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: -7984000.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Net PPE: 167710000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 167710000.00
REGENCERAM.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: 0.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: -839388000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -839388000.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: -207943000.00
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -113441000.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — Normalized Income: -238448000.00
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — Normalized Income: -124940000.00
REGENCERAM.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: -342943000.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — Operating Income: -273118000.00
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — Operating Income: -127664000.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — Operating Revenue: 382678000.00
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 112644000.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 26441586.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 26441586.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 391586000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 391586000.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 281209000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 281209000.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: -1103804000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: -1103804000.00
REGENCERAM.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: -22285000.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 18036000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 18036000.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 25930000.00
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 4202000.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 254052000.00
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 66377000.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 65993000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 65993000.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Payables: 482736000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Payables: 482736000.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — Pretax Income: -253307000.00
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — Pretax Income: -124940000.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 322608000.00
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 152592000.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 39245000.00
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 10021000.00
REGENCERAM.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 0.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Share Issued: 26441586.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 26441586.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: -839388000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: -839388000.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: -839388000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -839388000.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — Tax Provision: -14859000.00
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 0.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.06
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 3783000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 3783000.00
REGENCERAM.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: 14859000.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Total Assets: 1205698000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 1205698000.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 199952000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 199952000.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Total Debt: 1091756000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 1091756000.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: -839388000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: -839388000.00
REGENCERAM.NS income_statement (annual, 2026-03-31) — Total Expenses: 655796000.00
REGENCERAM.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 240308000.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 2045086000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 2045086000.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 260506000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 260506000.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1053870000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1053870000.00
REGENCERAM.NS balance_sheet (annual, 2026-03-31) — Working Capital: -46024000.00
REGENCERAM.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: -46024000.00
REGN balance_sheet (annual, 2021-12-31) — Current Capital Lease Obligation: 719700000.00
REGN balance_sheet (annual, 2021-12-31) — Current Debt And Capital Lease Obligation: 719700000.00
REGN balance_sheet (annual, 2021-12-31) — Current Deferred Assets: 448500000.00
REGN balance_sheet (annual, 2021-12-31) — Dueto Related Parties Current: 287400000.00
REGN cash_flow (annual, 2021-12-31) — Income Tax Paid Supplemental Data: 1218400000.00
REGN cash_flow (annual, 2021-12-31) — Issuance Of Debt: 0.00
REGN cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 0.00
REGN cash_flow (annual, 2021-12-31) — Long Term Debt Payments: 0.00
REGN cash_flow (annual, 2021-12-31) — Net Issuance Payments Of Debt: 0.00
REGN cash_flow (annual, 2021-12-31) — Net Long Term Debt Issuance: 0.00
REGN balance_sheet (annual, 2021-12-31) — Prepaid Assets: 332400000.00
REGN cash_flow (annual, 2021-12-31) — Repayment Of Debt: 0.00
REGN income_statement (annual, 2021-12-31) — Restructuring And Mergern Acquisition: 48000000.00
REGN income_statement (annual, 2022-12-31) — +Operating Expense: 5873600000.00
REGN income_statement (annual, 2022-12-31) — +Total Revenue: 12172900000.00
REGN balance_sheet (annual, 2022-12-31) — Accounts Payable: 589200000.00
REGN balance_sheet (annual, 2022-12-31) — Accounts Receivable: 5328700000.00
REGN balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -1669200000.00
REGN balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 9949300000.00
REGN cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 37600000.00
REGN cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 37600000.00
REGN balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 6591800000.00
REGN income_statement (annual, 2022-12-31) — Basic Average Shares: 107100000.00
REGN income_statement (annual, 2022-12-31) — Basic EPS: 40.51
REGN cash_flow (annual, 2022-12-31) — Beginning Cash Position: 2898100000.00
REGN balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 2270000000.00
REGN cash_flow (annual, 2022-12-31) — Capital Expenditure: -1616900000.00
REGN cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -590100000.00
REGN balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 720000000.00
REGN balance_sheet (annual, 2022-12-31) — Capital Stock: 100000.00
REGN balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 3105900000.00
REGN balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 7742300000.00
REGN cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -1009000000.00
REGN cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -3784600000.00
REGN cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 5014900000.00
REGN cash_flow (annual, 2022-12-31) — Change In Account Payable: -138400000.00
REGN cash_flow (annual, 2022-12-31) — Change In Inventory: -696500000.00
REGN cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 32400000.00
REGN cash_flow (annual, 2022-12-31) — Change In Payable: -138400000.00
REGN cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -138400000.00
REGN cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -148600000.00
REGN cash_flow (annual, 2022-12-31) — Change In Receivables: 707800000.00
REGN cash_flow (annual, 2022-12-31) — Change In Working Capital: -243300000.00
REGN cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 707800000.00
REGN cash_flow (annual, 2022-12-31) — Changes In Cash: 221300000.00
REGN balance_sheet (annual, 2022-12-31) — Common Stock: 100000.00
REGN balance_sheet (annual, 2022-12-31) — Common Stock Equity: 22664000000.00
REGN cash_flow (annual, 2022-12-31) — Common Stock Issuance: 1519500000.00
REGN cash_flow (annual, 2022-12-31) — Common Stock Payments: -2528500000.00
REGN balance_sheet (annual, 2022-12-31) — Construction In Progress: 980500000.00
REGN income_statement (annual, 2022-12-31) — Cost Of Revenue: 1560400000.00
REGN balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 2074200000.00
REGN balance_sheet (annual, 2022-12-31) — Current Assets: 15884100000.00
REGN balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 0.00
REGN balance_sheet (annual, 2022-12-31) — Current Deferred Assets: 521800000.00
REGN balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 477900000.00
REGN balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 477900000.00
REGN balance_sheet (annual, 2022-12-31) — Current Liabilities: 3141300000.00
REGN cash_flow (annual, 2022-12-31) — Deferred Income Tax: -746400000.00
REGN cash_flow (annual, 2022-12-31) — Deferred Tax: -746400000.00
REGN cash_flow (annual, 2022-12-31) — Depreciation: 303900000.00
REGN cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 341400000.00
REGN cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 341400000.00
REGN income_statement (annual, 2022-12-31) — Diluted Average Shares: 113500000.00
REGN income_statement (annual, 2022-12-31) — Diluted EPS: 38.22
REGN income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 4338400000.00
REGN balance_sheet (annual, 2022-12-31) — Dueto Related Parties Current: 10500000.00
REGN income_statement (annual, 2022-12-31) — EBIT: 4918200000.00
REGN income_statement (annual, 2022-12-31) — EBITDA: 5259600000.00
REGN cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 0.00
REGN cash_flow (annual, 2022-12-31) — End Cash Position: 3119400000.00
REGN cash_flow (annual, 2022-12-31) — Financing Cash Flow: -1009000000.00
REGN balance_sheet (annual, 2022-12-31) — Finished Goods: 98600000.00
REGN cash_flow (annual, 2022-12-31) — Free Cash Flow: 3398000000.00
REGN cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 36800000.00
REGN income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 10400000.00
REGN balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -238800000.00
REGN balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 915500000.00
REGN balance_sheet (annual, 2022-12-31) — Gross PPE: 5432200000.00
REGN income_statement (annual, 2022-12-31) — Gross Profit: 10612500000.00
REGN cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 1502400000.00
REGN balance_sheet (annual, 2022-12-31) — Income Tax Payable: 300000.00
REGN income_statement (annual, 2022-12-31) — Interest Expense: 59400000.00
REGN income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 59400000.00
REGN income_statement (annual, 2022-12-31) — Interest Income: 160100000.00
REGN income_statement (annual, 2022-12-31) — Interest Income Non Operating: 160100000.00
REGN cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 53700000.00
REGN balance_sheet (annual, 2022-12-31) — Inventory: 2401900000.00
REGN balance_sheet (annual, 2022-12-31) — Invested Capital: 24645400000.00
REGN cash_flow (annual, 2022-12-31) — Investing Cash Flow: -3784600000.00
REGN balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 6591800000.00
REGN balance_sheet (annual, 2022-12-31) — Investments And Advances: 6591800000.00
REGN cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 1519500000.00
REGN cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
REGN balance_sheet (annual, 2022-12-31) — Land And Improvements: 264500000.00
REGN balance_sheet (annual, 2022-12-31) — Leases: 114300000.00
REGN balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 720000000.00
REGN balance_sheet (annual, 2022-12-31) — Long Term Debt: 1981400000.00
REGN balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 2701400000.00
REGN cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
REGN cash_flow (annual, 2022-12-31) — Long Term Debt Payments: 0.00
REGN balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 487600000.00
REGN cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -230300000.00
REGN cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -1009000000.00
REGN income_statement (annual, 2022-12-31) — Net Income: 4338400000.00
REGN income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 4338400000.00
REGN income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 4338400000.00
REGN income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 4338400000.00
REGN income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 4338400000.00
REGN cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 4338400000.00
REGN income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 4338400000.00
REGN cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -1026800000.00
REGN income_statement (annual, 2022-12-31) — Net Interest Income: 100700000.00
REGN cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -1937400000.00
REGN cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 0.00
REGN cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 0.00
REGN income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 100700000.00
REGN cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -230300000.00
REGN balance_sheet (annual, 2022-12-31) — Net PPE: 3763000000.00
REGN cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: 0.00
REGN balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 21748500000.00